Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/12/2003 | CA2469356A1 Nuclear protein "shoca" - a component of the wnt signalling pathway |
06/12/2003 | CA2469104A1 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors |
06/12/2003 | CA2468991A1 Methods and reagents for diagnosis and treatment of diabetes |
06/12/2003 | CA2468851A1 Gips, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein |
06/12/2003 | CA2468742A1 Cell culture media |
06/12/2003 | CA2468727A1 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters |
06/12/2003 | CA2468710A1 Chromosomal saturation mutagenesis |
06/12/2003 | CA2468701A1 T-bet compositions and methods of use thereof |
06/12/2003 | CA2468565A1 Transgenic animals bearing human iglambda light chain genes |
06/12/2003 | CA2468407A1 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
06/12/2003 | CA2468259A1 Antibody to latent membrane proteins and uses thereof |
06/12/2003 | CA2467363A1 Polycistronic expression of antibodies |
06/12/2003 | CA2466413A1 Flavivirus ns1 subunit vaccine |
06/12/2003 | CA2462966A1 Factor viii c2 domain variants |
06/12/2003 | CA2438297A1 Gene targeting methods and vectors |
06/11/2003 | EP1318401A2 Method for the early detection of the seroconversion of an anti hepatitis C virus antibody |
06/11/2003 | EP1318195A1 A structure for presenting desired peptide sequences |
06/11/2003 | EP1318193A2 D-amidase from Variovorax |
06/11/2003 | EP1317927A1 Minor histocompatibility antigen HA-1: target antigen for immunotherapy of tumors |
06/11/2003 | EP1317562A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
06/11/2003 | EP1317560A1 Self-rearranging dna vectors |
06/11/2003 | EP1317559A2 Dna transfection system for the generation of infectious influenza virus |
06/11/2003 | EP1317556A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug |
06/11/2003 | EP1317554A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
06/11/2003 | EP1317541A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
06/11/2003 | EP1317540A2 Imidazoline receptor homologs |
06/11/2003 | EP1317538A1 Novel compounds |
06/11/2003 | EP1317537A2 G-csf analog compositions and methods |
06/11/2003 | EP1317536A2 Tnf receptor-like molecules and uses thereof |
06/11/2003 | EP1317535A2 Constructs and their use in metabolic pathway engineering |
06/11/2003 | EP1317531A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
06/11/2003 | EP1317526A1 Bio-reactor device |
06/11/2003 | EP1317488A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
06/11/2003 | EP1317486A1 Interferon-alpha induced gene |
06/11/2003 | EP1317485A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
06/11/2003 | EP1317476A2 Reagents for cell selection and methods of use |
06/11/2003 | EP1317474A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
06/11/2003 | EP1317282A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS |
06/11/2003 | EP1317253A2 Biological component comprising artificial membrane |
06/11/2003 | EP1062349B1 Diisopropyl fluorophosphatase and the utilization and production thereof |
06/11/2003 | EP1051244A4 Method and articles for transfection of genetic material |
06/11/2003 | EP0930361B1 Cell compositions |
06/11/2003 | EP0848755B1 Vegf-related protein |
06/11/2003 | EP0707641B1 An enzyme with protease activity |
06/11/2003 | EP0690873B1 Growth differentiation factor-8 |
06/11/2003 | EP0665886B1 Cyclin complex rearrangement and uses related thereto |
06/11/2003 | EP0644900B1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and its use |
06/11/2003 | EP0638119B1 Chimeric receptor genes and cells transformed therewith |
06/11/2003 | CN1423702A Chemical inducible promoter used to obtain transgenic plants with a silent marker and organisms and cells and methods of using same for screening for mutations |
06/11/2003 | CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex |
06/11/2003 | CN1423693A Method for the production of vitamin A |
06/11/2003 | CN1423692A Human Muellerian Duct-derived epithelial cells and methods of isolation and uses thereof |
06/11/2003 | CN1423660A Antibodies |
06/11/2003 | CN1423659A Recombinant gelatins |
06/11/2003 | CN1423658A Modulation of human sodium channels in dorsal root ganglia |
06/11/2003 | CN1423657A Inter feron-alpha induced gene |
06/11/2003 | CN1423565A 精子因子oscillogenin Sperm factor oscillogenin |
06/11/2003 | CN1423563A Pancreatic stem cells and their use in transplantation |
06/11/2003 | CN1423561A Remedies for hepatitis C |
06/11/2003 | CN1423523A Human ex vivo immune system |
06/11/2003 | CN1423522A A method to produce cloned embryos and adults from cultured cells |
06/11/2003 | CN1423521A In OVO activation of an avian egg in the shell |
06/11/2003 | CN1422949A Method for producing and converting manioc protoplasm |
06/11/2003 | CN1422948A Plant cell culture medium and method for culturing plant cell using said culture medium |
06/11/2003 | CN1422672A Absorbable calcined-bone preparation method |
06/10/2003 | US6576820 Rice cell transformed with a gene encoding the protein; useful as an ingredient in food and for preventing and treating arteriosclerosis and coronary heart diseases; lowers serum cholesterol |
06/10/2003 | US6576818 Isolated polynucleotide of given sequence; use in altering the phenotype of cotton fiber |
06/10/2003 | US6576758 Nucleic acid constructs containing hybrid promoters |
06/10/2003 | US6576756 Nucleotide sequences coding polypetide for use in the diagnosis and treatment of cancer |
06/10/2003 | US6576751 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
06/10/2003 | US6576745 Human cystatin F antibodies |
06/10/2003 | US6576609 Methods and compositions for generating angiostatin |
06/10/2003 | US6576608 Stimulating tyrosine phosphorylation of Flt4 tyrosine kinase receptor in Flt4-expressing cell |
06/10/2003 | US6576468 Methods for obtaining microbe-resistant mammalian cells from hypermutable mammalian cells |
06/10/2003 | US6576466 Activation; separation |
06/10/2003 | US6576465 Human bone accessory cells |
06/10/2003 | US6576464 Methods for providing differentiated stem cells |
06/10/2003 | US6576455 Structure-based designed herbicide resistant products |
06/10/2003 | US6576439 Contacting protein of given sequence with a test compound and detecting modulating activity; drug screening; can use for treatment of inflammatory conditions |
06/10/2003 | US6576437 Stimulus-inducible protein kinase complex and methods of use therefor |
06/10/2003 | US6576433 Method for identification of cell growth or differentiation factors |
06/10/2003 | US6576428 Direct selection of antigen-specific T cells, compositions obtained thereby and methods of use thereof |
06/10/2003 | US6576218 Transplacental delivery of oligonucleotides |
06/10/2003 | CA2081879C Monoclonal antibodies to polyacrylate polymers |
06/05/2003 | WO2003046511A2 Magneto-optical bio-discs and systems including related methods |
06/05/2003 | WO2003046506A2 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies |
06/05/2003 | WO2003046191A1 Method for culturing dendritic cells |
06/05/2003 | WO2003046190A1 Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors |
06/05/2003 | WO2003046189A1 Flavivirus vaccine delivery system |
06/05/2003 | WO2003046187A1 Method for producing a recombinant polypeptide |
06/05/2003 | WO2003046181A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells |
06/05/2003 | WO2003046179A2 G-protein coupled receptor lustr2 and uses thereof |
06/05/2003 | WO2003046175A1 Dna construct for assessing thymic function activity and therapeutical uses thereof |
06/05/2003 | WO2003046174A1 Process for producing substance |
06/05/2003 | WO2003046161A2 Method for carrying out the ex vivo expansion and ex vivo differentiation of multipotent stem cells |
06/05/2003 | WO2003046141A2 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
06/05/2003 | WO2003046134A2 Expression of polypeptides in rod outer segment membranes |
06/05/2003 | WO2003046133A2 Regulatory nucleic acid assay for diagnostic and library screens |
06/05/2003 | WO2003046132A2 Antisense modulation of myd88 expression |
06/05/2003 | WO2003046131A2 Dnmt3l-related cloning and reproductive methods |